AbbVie has made significant strides in sustainability, with a goal to reduce its greenhouse gas emissions by 50% by 2025. This ambitious target is a testament to the company's commitment to environmental responsibility.
The company has already made notable progress, with a 25% reduction in emissions since 2015. This achievement demonstrates AbbVie's dedication to reducing its environmental footprint.
AbbVie's commitment to sustainability has also had a positive impact on its market success. The company's strong reputation for corporate responsibility has helped to attract and retain top talent, as well as build trust with customers and investors.
Readers also liked: Djsi Dow Jones Sustainability Index
Market Performance
The Dow Jones has had a significant impact on AbbVie's market performance. The Dow Jones Industrial Average (DJIA) is a stock market index that represents the performance of 30 major companies in the United States.
AbbVie's stock has been a part of the Dow Jones since 2013, when the company split from Abbott Laboratories. As a result, AbbVie's stock has been included in the Dow Jones average.
The Dow Jones average has experienced fluctuations over the years, but AbbVie's stock has generally performed well. In 2020, the Dow Jones average reached an all-time high, and AbbVie's stock price increased by over 10% during the same period.
Despite some volatility, AbbVie's stock has consistently traded above its 200-day moving average, indicating a strong upward trend. This trend is a positive sign for investors looking to buy or hold AbbVie's stock.
Sustainability Recognition
AbbVie has been recognized for its commitment to sustainability, earning top scores in various criteria.
The company has been named to the Dow Jones Sustainability World Index (DJSI World) for 10 consecutive years.
AbbVie received the highest score in the biotech sector on the 2022 S&P Global Corporate Sustainability Assessment (CSA).
The S&P Global CSA is an annual evaluation of companies' sustainability practices, covering over 10,000 companies globally.
AbbVie's achievements reflect its ongoing commitment to advance ESG initiatives that contribute to its sustainable growth.
A different take: Nifty 50 Top 10 Stocks
The company's top CSA ranking in the biotech sector is as of December 12, 2022.
AbbVie shares its progress and initiatives in its annual ESG Action Report.
The company's corporate responsibility commitments include improving health outcomes, operating responsibly, and contributing to communities.
AbbVie has been listed on the DJSI World and DJSI North America every year since its founding in 2013.
Here are the nine criteria where AbbVie received top scores in the biotech sector on the 2022 S&P Global CSA:
- Environmental Dimension: Environmental Reporting
- Social Dimension: Social Reporting, Human Rights, Human Capital Development, Talent Attraction & Retention and Access to Healthcare
- Governance & Economic Dimension: Materiality, Tax Strategy and Risk & Crisis Management
Frequently Asked Questions
Is AbbVie a buy, sell, or hold today?
According to analyst consensus, AbbVie is currently a Moderate Buy. Investors may want to consider this rating when deciding their next move.
Featured Images: pexels.com
